UBS raised the firm’s price target on Bloomin’ Brands to $28 from $23 and keeps a Neutral rating on the shares. The company in Q4 reported solid operating margin and earnings upside, a better than expected commodity inflation outlook, and 2023 guidance that was in line to better than expectations, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BLMN: